Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
NCT03631420
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Bronchopulmonary Dysplasia
Interventions
BIOLOGICAL:
Human Umbilical Cord Derived-Mesenchymal Stem Cells
Sponsor
Meridigen Biotech Co., Ltd.